Robert L. Zerbe, MD, Joins Aastrom Biosciences' Board of Directors ROBERT L. ZERBE, M.D., JOINS AASTROM BIOSCIENCES' BOARD OF DIRECTORS Ann Arbor, Michigan, January 17, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Robert L. Zerbe, M.D.

-- Long-Term CEO and Chairman to Continue at Board Level --

-- Results Indicate Company's Tissue Repair Cell Product Safely Builds New Bone for Dental Implants --

-- New Trial Expected to Further Company's Knowledge of Bone Regeneration --

-- Spine Fusion Trial at William Beaumont Hospital to Use Aastrom's Adult Stem Cell TRC Product --

Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2006 Financial Results Ann Arbor, Michigan, November 9 , 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the first quarter of fiscal year 2006 ended September 30, 2005.  The Company also reported

Aastrom Biosciences CEO to Present at Noble Financial Group Small Cap Conference Ann Arbor, Michigan, November 7, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Noble Financial Group Small Cap

Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call Ann Arbor, MI, November 4, 2005 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences First Quarter Fiscal Year End 2006 Investor Conference Call When: Wednesday,

Aastrom Biosciences CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference Ann Arbor, Michigan, November 3, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Rodman & Renshaw

Webcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of Shareholders Ann Arbor, MI, November 1, 2005 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences Fiscal Year End 2005 Annual Meeting of Shareholders When: Wednesday, November